Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Poised to Hit $2.17 Billion by 2029 with Accelerating Growth Trends

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Size Growth Forecast: What to Expect by 2025?
The market for tools facilitating the feasibility of clinical trial protocols through artificial intelligence has seen an unparalleled surge of late. It's projected to bolster from $0.65 billion in 2024 to $0.83 billion in 2025, indicating a compound annual growth rate (CAGR) of 27.5%. The ascent witnessed in this historical phase draws its roots from the escalating intricacies of clinical trial directives, an increased mass of clinical trial data, the soaring expenses of conventional clinical trials, heightened utilization of digital health files, and an amplified emphasis on trials revolving around patient welfare.

How Will the Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Size Evolve and Grow by 2029?
In the upcoming years, the market size of the artificial intelligence clinical trial protocol feasibility tool is predicted to experience massive growth. It is forecasted to rise to a value of $2.17 billion in 2029 with a compound annual growth rate (CAGR) of 27.1%. The surge anticipated in the forecast period can be ascribed to the burgeoning demand for personalized medicine trials, the escalating adoption of decentralized clinical trials, a rise in the utilization of natural language processing, expanding focus on patient diversity in trials, and growing significance of real-time feasibility monitoring. Fundamental trends during the forecast period comprise the development of adaptive algorithms for optimizing site selection, incorporating genomic data to facilitate precision trial protocols, innovating automated trial cost and timeline estimation, creating tools to boost patient diversity in clinical trials, and integrating multi-source real-world evidence for accurate feasibility.

View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-clinical-trial-protocol-feasibility-tool-global-market-report

What Drivers Are Propelling the Growth of Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Forward?
As the focus on precision medicine gains traction, it's anticipated to fuel the expansion of the market for artificial intelligence clinical trial protocol feasibility tools. Precision medicine is a healthcare strategy tailored to the patient's genetic makeup, environment, and lifestyle for more targeted and efficacious treatments. The growing interest in this field is attributed to advancements in genomic sequencing and biomarker identification, which allow for accurate detection and tailored treatments. AI clinical trial protocol feasibility tools enhance precision medicine, assisting in data-driven trial designs that are optimal for specific patient groups. These tools minimize trial inefficiencies by providing predictions for patient recruitment, timeframes, and risks, thereby enhancing the precision and results of clinical research. For example, Novotech, an Australian biotechnology firm, confirmed in March 2024 that in 2023, 43% of the 217 FDA-approved oncology treatments were precision oncology treatments, with 78 featuring DNA or NGS-detectable biomarkers. Therefore, the burgeoning focus on precision medicine is a significant driver for the growth of the AI clinical trial protocol feasibility tool market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28142&type=smp

Which Emerging Trends Are Transforming the Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market in 2025?
Significant players in the market of artificial intelligence clinical trial protocol feasibility tools are concentrating on the creation of innovative solutions such as software for planning trials based on predictive analytics. This helps to improve the precision of protocol design and reduce delays in trials. This software solution utilises both real-time and historical clinical trial data to predict timelines, pinpoint potential risks, and refine study designs to make trials more cost-effective and efficient. For example, in June 2024, Lokavant Inc., an American clinical intelligence company, introduced Spectrum. This was the first tool for assessing the feasibility of clinical trials using AI, with the specific aim of optimising trials from the strategic planning stage to the mid-study re-forecasting stage. The platform houses software for planning trials based on predictive analytics, allowing for ongoing, real-time feasibility studies, along with the prediction of costs and timelines, and financial forecasting without the requirement for manual input. Spectrum also offers dynamic, real-time (re)forecasting by merging live trial data, allowing study groups to check progress, examine different potential scenarios, and improve enrolment results. Furthermore, this tool offers highly accurate estimations for costs, timelines, and operational risks, facilitating quicker, data-based decision making for the entire length of the clinical trial lifecycle.

What Are the Key Segments in the Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market?
The artificial intelligence clinical trial protocol feasibility tool market covered in this report is segmented as

1) By Component: Software, Services
2) By Deployment Mode: Cloud-Based, On-Premises
3) By Application: Protocol Design, Site Selection, Patient Recruitment, Risk Assessment, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users

Subsegments:
1) By Software: Predictive Analytics, Machine Learning, Natural Language Processing, Data Integration
2) By Services: Consulting, Implementation, Training And Support, Managed Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28142&type=smp

Who Are the Key Players Shaping the Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market's Competitive Landscape?
Major companies operating in the artificial intelligence clinical trial protocol feasibility tool market are IQVIA Holdings Inc., SAS Institute Inc., Veeva Systems Inc., Tempus AI Inc., Cytel Inc., ArisGlobal LLC., Saama Technologies Inc., Norstella, ConcertAI, Komodo Health Inc., H1 Inc., TriNetX Inc., ObjectiveHealth LLC, Lokavant Inc., Inato Inc., Clinerion Ltd., Faro Health Inc., Lantern Pharma Inc., Ryght AI, and BEKHealth Corporation.

What Geographic Markets Are Powering Growth in the Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market?
North America was the largest region in the artificial intelligence clinical trial protocol feasibility tool market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence clinical trial protocol feasibility tool report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28142

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.